BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28457181)

  • 1. New AMH assay allows rapid point of care measurements of ovarian reserve.
    Pastuszek E; Lukaszuk A; Kunicki M; Mockun J; Kloss G; Malinowska I; Czyzyk A; Meczekalski B; Lukaszuk K
    Gynecol Endocrinol; 2017 Aug; 33(8):638-643. PubMed ID: 28457181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New automated antimüllerian hormone assays are more reliable than the manual assay in patients with reduced antral follicle count.
    Tadros T; Tarasconi B; Nassar J; Benhaim JL; Taieb J; Fanchin R
    Fertil Steril; 2016 Dec; 106(7):1800-1806. PubMed ID: 27692436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
    Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
    Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian hormone assays.
    Nelson SM; Pastuszek E; Kloss G; Malinowska I; Liss J; Lukaszuk A; Plociennik L; Lukaszuk K
    Fertil Steril; 2015 Oct; 104(4):1016-1021.e6. PubMed ID: 26183313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.
    Anderson RA; Anckaert E; Bosch E; Dewailly D; Dunlop CE; Fehr D; Nardo L; Smitz J; Tremellen K; Denk B; Geistanger A; Hund M
    Fertil Steril; 2015 Apr; 103(4):1074-1080.e4. PubMed ID: 25681853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
    Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
    Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre evaluation of the Elecsys
    Jacobs MH; Reuter LM; Baker VL; Craig LB; Sakkas D; Surrey E; Doody KJ; Jungheim ES; Bayrak AB; Hund M; Verhagen-Kamerbeek WDJ; Pardue D; Buck K; Timm B
    Reprod Biomed Online; 2019 May; 38(5):845-852. PubMed ID: 30930183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-equivalence of anti-Müllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing.
    Iliodromiti S; Salje B; Dewailly D; Fairburn C; Fanchin R; Fleming R; Li HWR; Lukaszuk K; Ng EHY; Pigny P; Tadros T; van Helden J; Weiskirchen R; Nelson SM
    Hum Reprod; 2017 Aug; 32(8):1710-1715. PubMed ID: 28854583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ovarian reserve markers in prediction of clinical pregnancy.
    Zebitay AG; Cetin O; Verit FF; Keskin S; Sakar MN; Karahuseyinoglu S; Ilhan G; Sahmay S
    J Obstet Gynaecol; 2017 May; 37(4):492-497. PubMed ID: 28421902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
    Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
    Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K; Zander-Fox D
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal serum anti-Mullerian hormone (AMH) is a promising test in prediction of occurrence of pregnancy rate in infertile women undergoing ICSI cycles.
    Kamel HM; Amin AH; Al-Adawy AR
    Clin Lab; 2014; 60(10):1717-23. PubMed ID: 25651719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?
    Scheffer JAB; Scheffer B; Scheffer R; Florencio F; Grynberg M; Lozano DM
    JBRA Assist Reprod; 2018 Sep; 22(3):215-220. PubMed ID: 29949322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy.
    Srebnik N; Margalioth EJ; Rabinowitz R; Varshaver I; Altarescu G; Renbaum P; Levi-Lahad E; Weintraub A; Eldar-Geva T
    Reprod Biomed Online; 2014 Jul; 29(1):94-101. PubMed ID: 24813161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
    Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
    Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the lower serum anti-Müllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys® AMH assay: a prospective observational study.
    Grynnerup AG; Løssl K; Pilsgaard F; Lunding SA; Storgaard M; Bogstad JW; Prætorius L; Zedeler A; Bungum L; Nyboe Andersen A; Pinborg A
    Reprod Biol Endocrinol; 2019 Jan; 17(1):11. PubMed ID: 30634990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.